COVID-19 UPDATE: All elective surgeries and procedures are cancelled until further notice. Please see our latest visitor policy. If you think you may have been exposed or have symptoms, please call your provider before visiting one of our locations. For more information, please visit our online COVID-19 Information Center or call the Montefiore-Einstein COVID-19 Hotline: 1-844-444-CV19 (1-844-444-2819).

ACTUALIZACIÓN SOBRE EL COVID-19: Todas las cirugías y operaciones quedan canceladas hasta nuevo aviso. Lea nuestras nuevas normas para visitas. Si cree que podría haber estado en contacto con la enfermedad o si presenta síntomas, por favor llame a su proveedor antes de acudir a cualquiera de nuestros centros. Más información en nuestro Centro de Información en Línea sobre el COVID-19 o llamando a la línea informativa Montefiore-Einstein de COVID-19: 1-844-444-CV19 (1-844-444-2819).

Espanol
Radiation Oncology Research
Home >  Cancer (Oncology) >  Research and Clinical Trials >  Radiation Oncology Research
Print

Research and Clinical Trials

Radiation Oncology Research

As the University Hospital and Academic Medical Center for the Albert Einstein College of Medicine (AECOM) and a NCI-designated clinical cancer center, we believe very strongly in using the power of research to improve technologies, therapies and, most importantly, patient outcomes. That is why our entire team of radiation oncologists and physicists, all faculty members at AECOM, are involved in a large array of studies.

Currently, research is being conducted in the following:

  • Advanced physics technology such as IG-IMRT, 4D targeting, PET CT and biological treatment planning
  • Advanced brachytherapy for lung, prostate and gynecologic cancers
  • Advanced imaging technologies in radiation oncology: PET CT and MR spectroscopy treatment planning
  • Radiation enhanced tumor vaccines
  • Radiation and hepatocellular transplantation
  • Genetics and tissue dynamics of radioprotectant agents
  • Breast cancer and women's oncologic health
  • Angiogenesis, anti-angiogenesis and radiation
  • Quality of life and patterns of care
  • IMRT and IG-IMRT standardization and dose measurement
  • Target motion management and new technology development
  • Breast cancer irradiation
  • Inverse treatment planning
  • Health disparities